About Solute carrier family 46 member 2
Solute carrier family 46 member 2 (SLC46A2) is a protein
from Homo sapiens identified by UniProt accession
Q9BY10, 475 residues long.
MolForge cross-references it against 0 known binders and
34 disease associations.
Target properties
| Protein name | Solute carrier family 46 member 2 |
| UniProt accession | Q9BY10 |
| Gene | SLC46A2 |
| Organism | Homo sapiens |
| Length | 475 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (34)
Diseases linked to this target (Open Targets).
- hematocrit · score 0.38
- hemoglobin measurement · score 0.34
- red blood cell density measurement · score 0.27
- erythrocyte count · score 0.16
- neurofibrillary tangles measurement · score 0.06
- PHF-tau measurement · score 0.06
- blood protein measurement · score 0.04
- short-limb skeletal dysplasia with severe combined immunodeficiency · score 0.03
- non-small cell lung carcinoma · score 0.03
- neoplasm · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BY10-F1 | alphafold | PREDICTED | 80.58 | — |
Amino-acid sequence (475 residues)
MSPEVTCPRR GHLPRFHPRT WVEPVVASSQ VAASLYDAGL LLVVKASYGT GGSSNHSASP SPRGALEDQQ QRAISNFYII YNLVVGLSPL LSAYGLGWLS DRYHRKISIC MSLLGFLLSR LGLLLKVLLD WPVEVLYGAA ALNGLFGGFS AFWSGVMALG SLGSSEGRRS VRLILIDLML GLAGFCGSMA SGHLFKQMAG HSGQGLILTA CSVSCASFAL LYSLLVLKVP ESVAKPSQEL PAVDTVSGTV GTYRTLDPDQ LDQQYAVGHP PSPGKAKPHK TTIALLFVGA IIYDLAVVGT VDVIPLFVLR EPLGWNQVQV GYGMAAGYTI FITSFLGVLV FSRCFRDTTM IMIGMVSFGS GALLLAFVKE TYMFYIARAV MLFALIPVTT IRSAMSKLIK GSSYGKVFVI LQLSLALTGV VTSTLYNKIY QLTMDMFVGS CFALSSFLSF LAIIPISIVA YKQVPLSPYG DIIEK
Explore Solute carrier family 46 member 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets